Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
39.07
+0.98 (2.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
Select Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 6,969 | 6,664 | 6,334 | 6,205 | 5,532 | 5,454 | Upgrade
|
Revenue Growth (YoY) | 5.80% | 5.22% | 2.08% | 12.16% | 1.43% | 7.33% | Upgrade
|
Cost of Revenue | 5,567 | 5,350 | 5,236 | 4,941 | 4,374 | 4,318 | Upgrade
|
Gross Profit | 1,402 | 1,314 | 1,098 | 1,264 | 1,157 | 1,136 | Upgrade
|
Selling, General & Admin | 586.9 | 552.53 | 517.23 | 491.12 | 474.09 | 451.58 | Upgrade
|
Other Operating Expenses | -4.14 | -1.77 | -4.97 | -0.33 | - | - | Upgrade
|
Operating Expenses | 794.89 | 759.51 | 718.09 | 693.43 | 679.75 | 664.16 | Upgrade
|
Operating Income | 607.15 | 554.87 | 379.48 | 570.07 | 477.65 | 471.88 | Upgrade
|
Interest Expense | -194.11 | -198.64 | -169.11 | -135.99 | -153.01 | -200.57 | Upgrade
|
Interest & Investment Income | - | - | - | 5.35 | - | - | Upgrade
|
Earnings From Equity Investments | 60 | 40.81 | 26.41 | 44.43 | 29.44 | 24.99 | Upgrade
|
EBT Excluding Unusual Items | 473.04 | 397.05 | 236.78 | 483.87 | 354.07 | 296.3 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | 2.16 | 12.39 | 6.53 | Upgrade
|
Legal Settlements | - | - | - | 19.9 | - | - | Upgrade
|
Other Unusual Items | -10.94 | -14.69 | 23.8 | 123.8 | 90.01 | -38.08 | Upgrade
|
Pretax Income | 462.11 | 382.36 | 260.58 | 629.72 | 456.47 | 264.75 | Upgrade
|
Income Tax Expense | 107.36 | 82.63 | 62.55 | 129.77 | 111.87 | 63.72 | Upgrade
|
Earnings From Continuing Operations | 354.75 | 299.73 | 198.03 | 499.95 | 344.61 | 201.03 | Upgrade
|
Minority Interest in Earnings | -78.39 | -56.24 | -39.03 | -97.72 | -85.61 | -52.58 | Upgrade
|
Net Income | 276.36 | 243.49 | 158.99 | 402.23 | 259 | 148.45 | Upgrade
|
Preferred Dividends & Other Adjustments | 10.55 | 8.77 | 5.61 | 13.44 | 8.9 | 5 | Upgrade
|
Net Income to Common | 265.8 | 234.72 | 153.39 | 388.79 | 250.1 | 143.45 | Upgrade
|
Net Income Growth | 22.98% | 53.14% | -60.47% | 55.30% | 74.47% | 7.70% | Upgrade
|
Shares Outstanding (Basic) | 124 | 123 | 125 | 130 | 130 | 130 | Upgrade
|
Shares Outstanding (Diluted) | 124 | 123 | 125 | 130 | 130 | 130 | Upgrade
|
Shares Change (YoY) | 1.07% | -1.22% | -4.32% | 0.36% | -0.38% | 0.02% | Upgrade
|
EPS (Basic) | 2.14 | 1.91 | 1.23 | 2.98 | 1.93 | 1.10 | Upgrade
|
EPS (Diluted) | 2.14 | 1.91 | 1.23 | 2.98 | 1.93 | 1.10 | Upgrade
|
EPS Growth | 21.44% | 54.92% | -58.77% | 54.89% | 75.01% | 7.61% | Upgrade
|
Free Cash Flow | 352.52 | 352.86 | 94.45 | 220.69 | 881.63 | 288.06 | Upgrade
|
Free Cash Flow Per Share | 2.84 | 2.87 | 0.76 | 1.69 | 6.79 | 2.21 | Upgrade
|
Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.500 | - | - | Upgrade
|
Gross Margin | 20.12% | 19.72% | 17.33% | 20.36% | 20.92% | 20.83% | Upgrade
|
Operating Margin | 8.71% | 8.33% | 5.99% | 9.19% | 8.63% | 8.65% | Upgrade
|
Profit Margin | 3.81% | 3.52% | 2.42% | 6.27% | 4.52% | 2.63% | Upgrade
|
Free Cash Flow Margin | 5.06% | 5.29% | 1.49% | 3.56% | 15.94% | 5.28% | Upgrade
|
EBITDA | 819.29 | 763.62 | 585.31 | 772.72 | 683.3 | 684.46 | Upgrade
|
EBITDA Margin | 11.76% | 11.46% | 9.24% | 12.45% | 12.35% | 12.55% | Upgrade
|
D&A For EBITDA | 212.14 | 208.74 | 205.83 | 202.65 | 205.66 | 212.58 | Upgrade
|
EBIT | 607.15 | 554.87 | 379.48 | 570.07 | 477.65 | 471.88 | Upgrade
|
EBIT Margin | 8.71% | 8.33% | 5.99% | 9.19% | 8.63% | 8.65% | Upgrade
|
Effective Tax Rate | 23.23% | 21.61% | 24.01% | 20.61% | 24.51% | 24.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.